JENKINS GEORGE M — SEC insider filings
SEC reporting owner CIK 1271081. 9 insider filings on record with FilingPulse; latest filed 2026-10-14.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-12-17 to 2026-10-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 4 filings — 13,435 shares, $702,491 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 26 legs across 2 filings — 55,000 shares, $7,746,622 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 3.
- Largest priced transaction: sale of 6,520 shares @ $150.62 ($982,035) in PALVELLA THERAPEUTICS, INC., filed 2026-09-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PALVELLA THERAPEUTICS, INC. (PVLA) | Director | 9 | 5 legs · 13,435 sh · $702,491 | 26 legs · 55,000 sh · $7,746,622 | 3 |
Insider filings — JENKINS GEORGE M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-14 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Sale (S): 5,095 @ $132.62 · Sale (S): 2,458 @ $133.25 · Sale (S): 3,335 @ $134.21 · Sale (S): 1,447 @ $135.50 · Sale (S): 817 @ $136.44 · Sale (S): 2,004 @ $128.52 · +11 more | EDGAR |
| 2026-09-15 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Sale (S): 6,520 @ $150.62 · Sale (S): 4,577 @ $151.72 · Sale (S): 1,274 @ $153.06 · Sale (S): 5,632 @ $151.46 · Sale (S): 6,160 @ $152.12 · Sale (S): 1,560 @ $153.10 · +3 more | EDGAR |
| 2026-06-12 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Grant/award (A): 3,000 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Purchase (P): 445 @ $112.30 | EDGAR |
| 2026-03-02 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Purchase (P): 4,000 @ $125 | EDGAR |
| 2025-06-11 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Grant/award (A): 12,350 (derivative) @ $0 | EDGAR |
| 2025-04-10 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Purchase (P): 2,500 @ $20.13 · Purchase (P): 2,490 @ $20.27 | EDGAR |
| 2024-12-19 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Purchase (P): 4,000 @ $12.93 | EDGAR |
| 2024-12-17 | 4 | PALVELLA THERAPEUTICS, INC. (PVLA) | Grant/award (A): 24,700 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2022-05-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1271081 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs